GlobeNewswire by notified

Less than half of veterinary professionals feel their profession is appreciated

Share
  • World Veterinary Day 2024 celebrates the essential work of veterinarians, yet new data show only 49% of veterinary professionals believe their profession is appreciated.
  • Veterinary associations and Boehringer Ingelheim unite to help address this issue—starting with showcasing often-unseen aspects of the veterinary profession.

The World Veterinary Association’s theme for World Veterinary Day this year (April 27, 2024) highlights that veterinarians are essential health workers. Without veterinarians, food safety cannot be guaranteed, animals suffer needlessly, and humans face a higher risk of exposure to dangerous infectious diseases. Yet access to veterinary care should not be taken for granted as many veterinarians are currently considering leaving their chosen career, most often due to reasons associated with work-life balance and their mental health.1

Today Boehringer Ingelheim released findings from a survey of 1056 companion animal, livestock, and equine veterinarians in the United States, Japan, United Kingdom, France, Brazil, and Germany, to explore if veterinarians feel valued and understood by animal owners. A main finding of the study is that only 49% of veterinarians feel that the veterinary profession in general is appreciated.

“Understanding the reasons why veterinarians feel their profession is underappreciated, raising awareness of often-unseen and complex aspects of veterinary work, and most importantly, showing veterinary professionals that we recognize their essential work, is an important first step,” remarks Fabio Paganini, Member of the Global Animal Health Executive Committee at Boehringer Ingelheim. “As a veterinarian myself, I know that there is so much to love about this job. Together, we can showcase the relentless dedication, the genuine compassion, and the scientific know-how it takes to work as a veterinarian. It truly is a vocation to aspire to.”

Perceived levels of appreciation for the veterinary profession were relatively consistent across key types of veterinary teams — with only 48% of pet-focused (cats and dogs), 55% of livestock and 42% of equine veterinary professionals reporting that their profession was appreciated. This is despite 75% of survey respondents reporting feeling personally appreciated by their client base.

“We should not stand quietly as our colleagues leave the ring due to stress and burnout,” remarked Dr Ellen Van Nierop, President at World Small Animal Veterinary Association. “Veterinarians are exceptional professionals, who play an essential role in directly maintaining and improving the health and well-being of animals and indirectly, of the whole society. It is imperative that we shine a light on the often-unseen care and effort veterinarians put into forging a healthy and happy society.”

Digging deeper: what underpins appreciation levels?
Veterinary professionals believe their personal clients appreciate their “level of expertise” (reported by 66% of veterinarians surveyed), the “ability to deal with ethical dilemmas (including euthanasia)” (61% of veterinarians) and the fact “they provide a large variety of care” (57% of veterinarians). However, the survey also revealed that clients don’t always have full awareness of how far veterinarians push themselves to provide care. Of all participants, 49% felt they were underappreciated by clients when it came to understanding the “resilience to stress and emotional exhaustion” required from the job, with 48% reporting an underappreciation of the fact they “work despite feeling physically exhausted” and the way they “trade-off their work-life-balance to help animals”.

What needs to be done?
All survey respondents were asked to state a key aspect of their profession that they wish people knew more about. The most common responses from pet-focused participants were “our compassion and dedication to animal welfare i.e. not money” and “our commitment to being a veterinarian and the difficulties of the role”. Similarly, the most common response from both livestock and equine veterinary professionals was the “importance, competence and value of the profession”.

Boehringer Ingelheim, together with the Word Small Animal Vet Association (WSAVA) and the World Association for Buiatrics, plus other leading organizations, are united to help veterinarians — starting with showcasing veterinary professionals’ compassion and dedication to animal welfare, while shedding light on the often-unseen complex and difficult aspects of care.  

To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

“By celebrating the essential behind-the-scenes work veterinarians do, we can help them feel seen and appreciated so that they hopefully retain their passion for animal care for as long as possible,” shared Prof. Arcangelo Gentile, President of the World Association for Buiatrics. “World Veterinary Day 2024 (April 27) serves as the perfect opportunity to raise awareness of what really happens behind the clinic, farm and stable doors.” Countless young people are dreaming of becoming a veterinarian. We want them to understand the beautiful, complex, raw, fascinating, and touching reality behind the dream. And we want them to know how rich a life lived as a veterinarian can be.

Going Beyond 2024 survey(implemented by Kynetec, on behalf of Boehringer Ingelheim)
“We're proud to have partnered with Boehringer Ingelheim on this project. Working together, we were able to provide significant insight that we believe will lead to increased understanding of the care that veterinarians provide and make their essential professional engagement widely recognized in the public,” commented Dr. Jan Bahlmann, Kynetec's Head of Animal Health Customer Insights (Europe).

Top-line survey design
The survey was conducted from mid to end of March 2024 across 1056 veterinarians in Brazil (212), Japan (201), United Kingdom (170), France (162), United States (160) and Germany (151). The survey scope included companion animal (57%), equine (5%), dairy (10%), beef (8%), swine (6%) and poultry (3%) specialist veterinarians as well as mixed practices without a main focus (11%). Computer-assisted web as well as telephone interviews in local language were used to collect the data.

Going Beyond campaign
Going Beyond is a campaign developed by Boehringer Ingelheim with support from industry partners and veterinary associations to raise awareness of, and celebrate, the essential behind-the-scenes care that veterinarians provide for animals and communities worldwide. This care, which often goes unseen by animal owners, can leave veterinarians feeling underappreciated, contributing to poor mental health. Launching around World Veterinary Day 2024, Going Beyond aims to tackle this issue head-on by showcasing the boundless dedication, resilience and passion of veterinarians who care for animals in often challenging circumstances. The ultimate goal is to help veterinarians feel seen, appreciated and motivated to continue doing what they do best – caring for our beloved animals.

Kynetec
Kynetec is a global provider of data, analytics and insights in agriculture, animal health and nutrition. We empower agribusinesses and animal health and nutrition companies to make data-driven decisions, from strategy to execution, through predictive analytics and advanced insights. What sets us apart is our direct access to the markets we serve - farmers, veterinarians, pet owners, and agricultural experts - and our deep understanding of the complex dynamics that shape those markets. We regularly undertake data and analytics projects in all the major agricultural and animal health/nutrition markets, spanning more than 80 countries, to provide the insights that enable our clients to build winning strategies and brands. Kynetec’s responsibilities in this campaign work included empirical research co-design, survey execution and analytics.

Boehringer Ingelheim - Animal Health business
Boehringer Ingelheim provides innovation for preventing and treating diseases in animals. The company offers a wide range of vaccines, parasite-control products, and medicines for pets, horses, and livestock to veterinarians, animal owners, farmers, and governments. As a leader in animal health, Boehringer Ingelheim values that the health of humans and animals is deeply connected and strives to make a difference for people, animals, and society. Learn more at www.boehringer-ingelheim.com/animal-health.

Boehringer Ingelheim
Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. More than 53,500 employees serve over 130 markets to build a healthier, more sustainable, and equitable tomorrow. Learn more at www.boehringer-ingelheim.com

Intended Audiences Notice
This press release is issued from our Corporate Headquarters in Ingelheim, Germany, and is intended to provide information about our global business. Please be aware that information relating to the approval status and labels of approved products may vary from country to country, and a country-specific press release on this topic may have been issued in the countries where we do business.

To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.



1 Nolen RS., AVMA. Practice Inefficiencies Compound Veterinary Stress. (2021). Available at: https://www.avma.org/javma-news/2021-12-01/practice-inefficiencies-compound-veterinary-stress Last accessed April 2024.

Attachments

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Summary Notice of Pendency and Proposed Settlement of Shareholder Derivative Actions3.5.2024 22:39:16 CEST | Press release

CUPERTINO, Calif., May 03, 2024 (GLOBE NEWSWIRE) -- Apple Inc. has released the following notice: A Federal Court authorized this Notice. This is not a solicitation from a lawyer. TO: ALL PERSONS OR ENTITIES WHO OR WHICH HELD SHARES OF APPLE INC. (“APPLE” OR THE “COMPANY”) COMMON STOCK AS OF THE CLOSE OF TRADING ON APRIL 29, 2024. THIS NOTICE RELATES TO THE PENDENCY AND PROPOSED SETTLEMENT OF SHAREHOLDER DERIVATIVE LITIGATION. PLEASE READ THIS NOTICE CAREFULLY AND IN ITS ENTIRETY. IF YOU ARE A CURRENT APPLE SHAREHOLDER, THIS NOTICE CONTAINS IMPORTANT INFORMATION ABOUT YOUR RIGHTS. THIS ACTION IS NOT A “CLASS ACTION.” THUS, THERE IS NO COMMON FUND UPON WHICH YOU CAN MAKE A CLAIM FOR MONETARY PAYMENT. IF YOU DO NOT OBJECT TO THE TERMS OF THE PROPOSED SETTLEMENT OR THE AMOUNT OF ATTORNEYS’ FEES AND EXPENSES DESCRIBED IN THIS NOTICE, YOU ARE NOT OBLIGATED TO TAKE ANY ACTION. The purpose of this Notice is to inform you of: (i) the pendency of the shareholder derivative action brought on beh

CNH announces voting results of 2024 Annual General Meeting and publishes 2023 Sustainability Report3.5.2024 22:30:00 CEST | Press release

Basildon, May 3, 2024 CNH Industrial N.V. (NYSE: CNHI) today held its annual general meeting of shareholders. Shareholders re-appointed the Company’s director nominees, including Suzanne Heywood and Scott W. Wine as executive directors1, and Elizabeth Bastoni, Howard W. Buffett, Richard J. Kramer, Karen Linehan, Alessandro Nasi, Vagn Sørensen and Åsa Tamsons as non-executive directors. Shareholders also approved a dividend of $0.47 per common share (equivalent to a total distribution of approximately $585 million), and the AGM approved the Company’s Remuneration Policy. In other voting, shareholders appointed Deloitte Accountants B.V. as the independent auditor for the 2025 financial year and approved the Company’s 2023 financial statements prepared under IFRS. Details of all matters approved today by the AGM are available on the Company's website (www.cnh.com). *** The dividend is payable on May 29, 2024 to shareholders of record on May 13, 2024. Shareholders holding CNH common shares

Nokia Corporation: Repurchase of own shares on 03.05.20243.5.2024 21:30:00 CEST | Press release

Nokia Corporation Stock Exchange Release 03 May 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 03.05.2024 Espoo, Finland – On 03 May 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL379,8083.44CEUX--BATE--AQEU--TQEX--Total379,8083.44 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of tra

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons3.5.2024 19:48:16 CEST | Press release

Bagsværd, Denmark, 3 May 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company’s board members, executives and their associated persons have reported the transactions to Novo Nordisk and have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company’s board members, executives and their associated persons. Please find below a statement of such trading in shares issued by Novo Nordisk. Details of the person discharging managerial responsibilities/person closely associated a)Name of the Board member/Executive/Associated PersonMaziar Mike Doustdar2 Reason for the notificationa)Position/statusExecutive Vice Presidentb)Initial notification/AmendmentInitial notification3 Details of the issuera)NameNovo Nordisk A/Sb)LEI549300DAQ1CVT6CXN342

Subsea 7 S.A. notification of major holding3.5.2024 18:32:01 CEST | Press release

Luxembourg –3 May 2024 – Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced that, on 3 May 2024, Barclays Capital Securities Limited1 informed the Company that it had breached thresholds provided for by Luxembourg’s Transparency Law of 11 January 2008 on transparency requirements for issuers of securities as amended (the “Transparency Law”) as follows: On 30 April 2024 the total number of voting rights in the Company according to Article 8 and 9 of the Transparency Law attached to shares was 1,044,272 On 30 April 2024 the total number of voting rights in the Company attached to financial instruments with similar economic effect according to Article 12 (1) (a) of the Transparency Law (right to recall) was 13,906,019On 30 April 2024 the total number of voting rights in the Company attached to financial instruments with similar economic effect according to Article 12 (1) (b) of the Transparency Law (swaps) was 499,740 When combined, the above positions equate to 5.07% of voting r

HiddenA line styled icon from Orion Icon Library.Eye